nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Linagliptin—type 2 diabetes mellitus	0.156	0.235	CbGbCtD
Vecuronium—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.139	0.209	CbGbCtD
Vecuronium—SLC22A1—Metformin—type 2 diabetes mellitus	0.102	0.153	CbGbCtD
Vecuronium—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.1	0.151	CbGbCtD
Vecuronium—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.069	0.104	CbGbCtD
Vecuronium—ABCB1—Glyburide—type 2 diabetes mellitus	0.0514	0.0774	CbGbCtD
Vecuronium—ABCB1—Losartan—type 2 diabetes mellitus	0.047	0.0708	CbGbCtD
Vecuronium—Muscle atrophy—Irbesartan—type 2 diabetes mellitus	0.00929	0.0327	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Repaglinide—type 2 diabetes mellitus	0.00364	0.0128	CcSEcCtD
Vecuronium—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00291	0.0102	CcSEcCtD
Vecuronium—Immune system disorder—Linagliptin—type 2 diabetes mellitus	0.00272	0.00955	CcSEcCtD
Vecuronium—Mediastinal disorder—Linagliptin—type 2 diabetes mellitus	0.00271	0.00953	CcSEcCtD
Vecuronium—Angiopathy—Acarbose—type 2 diabetes mellitus	0.00265	0.00931	CcSEcCtD
Vecuronium—Erythema—Tolazamide—type 2 diabetes mellitus	0.00264	0.0093	CcSEcCtD
Vecuronium—Immune system disorder—Acarbose—type 2 diabetes mellitus	0.00264	0.00927	CcSEcCtD
Vecuronium—Face oedema—Sitagliptin—type 2 diabetes mellitus	0.00262	0.0092	CcSEcCtD
Vecuronium—Immune system disorder—Nateglinide—type 2 diabetes mellitus	0.00254	0.00894	CcSEcCtD
Vecuronium—Erythema—Acarbose—type 2 diabetes mellitus	0.00254	0.00893	CcSEcCtD
Vecuronium—Angioedema—Linagliptin—type 2 diabetes mellitus	0.00239	0.00841	CcSEcCtD
Vecuronium—Connective tissue disorder—Rosiglitazone—type 2 diabetes mellitus	0.00226	0.00795	CcSEcCtD
Vecuronium—Cardiac disorder—Repaglinide—type 2 diabetes mellitus	0.00226	0.00795	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00221	0.00778	CcSEcCtD
Vecuronium—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.0022	0.00774	CcSEcCtD
Vecuronium—Cardiac disorder—Rosiglitazone—type 2 diabetes mellitus	0.00214	0.00751	CcSEcCtD
Vecuronium—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00214	0.00751	CcSEcCtD
Vecuronium—Erythema—Repaglinide—type 2 diabetes mellitus	0.00212	0.00746	CcSEcCtD
Vecuronium—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00208	0.00731	CcSEcCtD
Vecuronium—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00207	0.00729	CcSEcCtD
Vecuronium—Connective tissue disorder—Pioglitazone—type 2 diabetes mellitus	0.0019	0.00667	CcSEcCtD
Vecuronium—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00188	0.00663	CcSEcCtD
Vecuronium—Flushing—Glipizide—type 2 diabetes mellitus	0.00187	0.00658	CcSEcCtD
Vecuronium—Connective tissue disorder—Sitagliptin—type 2 diabetes mellitus	0.00184	0.00648	CcSEcCtD
Vecuronium—Angioedema—Rosiglitazone—type 2 diabetes mellitus	0.00183	0.00644	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00179	0.0063	CcSEcCtD
Vecuronium—Cardiac disorder—Pioglitazone—type 2 diabetes mellitus	0.00179	0.0063	CcSEcCtD
Vecuronium—Erythema—Glipizide—type 2 diabetes mellitus	0.00175	0.00617	CcSEcCtD
Vecuronium—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.00174	0.00613	CcSEcCtD
Vecuronium—Mediastinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00174	0.00612	CcSEcCtD
Vecuronium—Cardiac disorder—Sitagliptin—type 2 diabetes mellitus	0.00174	0.00612	CcSEcCtD
Vecuronium—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00173	0.00608	CcSEcCtD
Vecuronium—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00171	0.00603	CcSEcCtD
Vecuronium—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00171	0.00603	CcSEcCtD
Vecuronium—Angiopathy—Sitagliptin—type 2 diabetes mellitus	0.0017	0.00598	CcSEcCtD
Vecuronium—Urticaria—Linagliptin—type 2 diabetes mellitus	0.0017	0.00597	CcSEcCtD
Vecuronium—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.00169	0.00595	CcSEcCtD
Vecuronium—Mediastinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00169	0.00594	CcSEcCtD
Vecuronium—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00168	0.00591	CcSEcCtD
Vecuronium—Connective tissue disorder—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00586	CcSEcCtD
Vecuronium—Rash—Miglitol—type 2 diabetes mellitus	0.00166	0.00585	CcSEcCtD
Vecuronium—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00166	0.00584	CcSEcCtD
Vecuronium—Urticaria—Acarbose—type 2 diabetes mellitus	0.00165	0.00579	CcSEcCtD
Vecuronium—Erythema—Glimepiride—type 2 diabetes mellitus	0.00164	0.00576	CcSEcCtD
Vecuronium—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00164	0.00575	CcSEcCtD
Vecuronium—Muscular weakness—Valsartan—type 2 diabetes mellitus	0.00163	0.00574	CcSEcCtD
Vecuronium—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.0016	0.00564	CcSEcCtD
Vecuronium—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00159	0.00559	CcSEcCtD
Vecuronium—Cardiac disorder—Bromocriptine—type 2 diabetes mellitus	0.00157	0.00554	CcSEcCtD
Vecuronium—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00157	0.00553	CcSEcCtD
Vecuronium—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00155	0.00546	CcSEcCtD
Vecuronium—Angiopathy—Bromocriptine—type 2 diabetes mellitus	0.00154	0.00541	CcSEcCtD
Vecuronium—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.00154	0.0054	CcSEcCtD
Vecuronium—Face oedema—Irbesartan—type 2 diabetes mellitus	0.00153	0.0054	CcSEcCtD
Vecuronium—Mediastinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00153	0.00538	CcSEcCtD
Vecuronium—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00153	0.00537	CcSEcCtD
Vecuronium—Angioedema—Glimepiride—type 2 diabetes mellitus	0.0015	0.00526	CcSEcCtD
Vecuronium—Rash—Tolbutamide—type 2 diabetes mellitus	0.0015	0.00526	CcSEcCtD
Vecuronium—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.00149	0.00524	CcSEcCtD
Vecuronium—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00147	0.00518	CcSEcCtD
Vecuronium—Face oedema—Losartan—type 2 diabetes mellitus	0.00144	0.00508	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00142	0.005	CcSEcCtD
Vecuronium—Shock—Glipizide—type 2 diabetes mellitus	0.00141	0.00495	CcSEcCtD
Vecuronium—Muscular weakness—Irbesartan—type 2 diabetes mellitus	0.0014	0.00493	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00138	0.00485	CcSEcCtD
Vecuronium—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00137	0.00483	CcSEcCtD
Vecuronium—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00137	0.00482	CcSEcCtD
Vecuronium—Rash—Tolazamide—type 2 diabetes mellitus	0.00136	0.00478	CcSEcCtD
Vecuronium—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00136	0.00478	CcSEcCtD
Vecuronium—Erythema—Glyburide—type 2 diabetes mellitus	0.00135	0.00475	CcSEcCtD
Vecuronium—Rash—Linagliptin—type 2 diabetes mellitus	0.00135	0.00474	CcSEcCtD
Vecuronium—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00135	0.00473	CcSEcCtD
Vecuronium—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00135	0.00473	CcSEcCtD
Vecuronium—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00134	0.0047	CcSEcCtD
Vecuronium—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00133	0.00468	CcSEcCtD
Vecuronium—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00133	0.00468	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.00133	0.00466	CcSEcCtD
Vecuronium—Muscular weakness—Losartan—type 2 diabetes mellitus	0.00132	0.00464	CcSEcCtD
Vecuronium—Shock—Glimepiride—type 2 diabetes mellitus	0.00131	0.00462	CcSEcCtD
Vecuronium—Rash—Acarbose—type 2 diabetes mellitus	0.00131	0.0046	CcSEcCtD
Vecuronium—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00131	0.00459	CcSEcCtD
Vecuronium—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00131	0.00459	CcSEcCtD
Vecuronium—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.0013	0.00459	CcSEcCtD
Vecuronium—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.0013	0.00457	CcSEcCtD
Vecuronium—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00129	0.00455	CcSEcCtD
Vecuronium—Flushing—Gliclazide—type 2 diabetes mellitus	0.00129	0.00454	CcSEcCtD
Vecuronium—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00128	0.00448	CcSEcCtD
Vecuronium—Rash—Nateglinide—type 2 diabetes mellitus	0.00126	0.00443	CcSEcCtD
Vecuronium—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00126	0.00443	CcSEcCtD
Vecuronium—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.00126	0.00442	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00125	0.00439	CcSEcCtD
Vecuronium—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00125	0.00439	CcSEcCtD
Vecuronium—Angioedema—Glyburide—type 2 diabetes mellitus	0.00123	0.00434	CcSEcCtD
Vecuronium—Erythema—Gliclazide—type 2 diabetes mellitus	0.00121	0.00426	CcSEcCtD
Vecuronium—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.00119	0.00418	CcSEcCtD
Vecuronium—Shock—Bromocriptine—type 2 diabetes mellitus	0.00119	0.00417	CcSEcCtD
Vecuronium—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00118	0.00416	CcSEcCtD
Vecuronium—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00118	0.00414	CcSEcCtD
Vecuronium—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00117	0.00412	CcSEcCtD
Vecuronium—Angiopathy—Valsartan—type 2 diabetes mellitus	0.00116	0.00408	CcSEcCtD
Vecuronium—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.00116	0.00406	CcSEcCtD
Vecuronium—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.00115	0.00405	CcSEcCtD
Vecuronium—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.00115	0.00403	CcSEcCtD
Vecuronium—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.00114	0.00402	CcSEcCtD
Vecuronium—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.00114	0.00401	CcSEcCtD
Vecuronium—Urticaria—Glipizide—type 2 diabetes mellitus	0.00114	0.004	CcSEcCtD
Vecuronium—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00396	CcSEcCtD
Vecuronium—Angioedema—Gliclazide—type 2 diabetes mellitus	0.00111	0.0039	CcSEcCtD
Vecuronium—Rash—Repaglinide—type 2 diabetes mellitus	0.00109	0.00384	CcSEcCtD
Vecuronium—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00109	0.00383	CcSEcCtD
Vecuronium—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00109	0.00383	CcSEcCtD
Vecuronium—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00109	0.00383	CcSEcCtD
Vecuronium—Shock—Glyburide—type 2 diabetes mellitus	0.00108	0.00381	CcSEcCtD
Vecuronium—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.00108	0.0038	CcSEcCtD
Vecuronium—Flushing—Metformin—type 2 diabetes mellitus	0.00108	0.0038	CcSEcCtD
Vecuronium—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00108	0.0038	CcSEcCtD
Vecuronium—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.00108	0.0038	CcSEcCtD
Vecuronium—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00106	0.00373	CcSEcCtD
Vecuronium—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00106	0.00372	CcSEcCtD
Vecuronium—Angiopathy—Metformin—type 2 diabetes mellitus	0.00106	0.00372	CcSEcCtD
Vecuronium—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00105	0.00371	CcSEcCtD
Vecuronium—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00105	0.0037	CcSEcCtD
Vecuronium—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.00105	0.00369	CcSEcCtD
Vecuronium—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00103	0.00363	CcSEcCtD
Vecuronium—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00103	0.00362	CcSEcCtD
Vecuronium—Hypotension—Glyburide—type 2 diabetes mellitus	0.00103	0.00362	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00103	0.0036	CcSEcCtD
Vecuronium—Flushing—Irbesartan—type 2 diabetes mellitus	0.00102	0.00359	CcSEcCtD
Vecuronium—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00102	0.00359	CcSEcCtD
Vecuronium—Angioedema—Valsartan—type 2 diabetes mellitus	0.00102	0.00358	CcSEcCtD
Vecuronium—Erythema—Metformin—type 2 diabetes mellitus	0.00101	0.00357	CcSEcCtD
Vecuronium—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00101	0.00355	CcSEcCtD
Vecuronium—Angioedema—Orlistat—type 2 diabetes mellitus	0.00101	0.00354	CcSEcCtD
Vecuronium—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000998	0.00351	CcSEcCtD
Vecuronium—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000993	0.00349	CcSEcCtD
Vecuronium—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000991	0.00348	CcSEcCtD
Vecuronium—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000984	0.00346	CcSEcCtD
Vecuronium—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000981	0.00345	CcSEcCtD
Vecuronium—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00097	0.00341	CcSEcCtD
Vecuronium—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000966	0.0034	CcSEcCtD
Vecuronium—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000961	0.00338	CcSEcCtD
Vecuronium—Flushing—Losartan—type 2 diabetes mellitus	0.00096	0.00338	CcSEcCtD
Vecuronium—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000958	0.00337	CcSEcCtD
Vecuronium—Erythema—Irbesartan—type 2 diabetes mellitus	0.000957	0.00337	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000942	0.00331	CcSEcCtD
Vecuronium—Angiopathy—Losartan—type 2 diabetes mellitus	0.000939	0.0033	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000931	0.00327	CcSEcCtD
Vecuronium—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000925	0.00325	CcSEcCtD
Vecuronium—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000909	0.0032	CcSEcCtD
Vecuronium—Rash—Glipizide—type 2 diabetes mellitus	0.000903	0.00317	CcSEcCtD
Vecuronium—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000902	0.00317	CcSEcCtD
Vecuronium—Erythema—Losartan—type 2 diabetes mellitus	0.000901	0.00317	CcSEcCtD
Vecuronium—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000898	0.00316	CcSEcCtD
Vecuronium—Shock—Valsartan—type 2 diabetes mellitus	0.000894	0.00314	CcSEcCtD
Vecuronium—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000892	0.00313	CcSEcCtD
Vecuronium—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000883	0.0031	CcSEcCtD
Vecuronium—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000881	0.0031	CcSEcCtD
Vecuronium—Urticaria—Glyburide—type 2 diabetes mellitus	0.000875	0.00308	CcSEcCtD
Vecuronium—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000875	0.00308	CcSEcCtD
Vecuronium—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000873	0.00307	CcSEcCtD
Vecuronium—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000872	0.00307	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000858	0.00302	CcSEcCtD
Vecuronium—Hypotension—Valsartan—type 2 diabetes mellitus	0.000849	0.00299	CcSEcCtD
Vecuronium—Rash—Glimepiride—type 2 diabetes mellitus	0.000843	0.00296	CcSEcCtD
Vecuronium—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000842	0.00296	CcSEcCtD
Vecuronium—Rash—Sitagliptin—type 2 diabetes mellitus	0.00084	0.00295	CcSEcCtD
Vecuronium—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000839	0.00295	CcSEcCtD
Vecuronium—Flushing—Ramipril—type 2 diabetes mellitus	0.000824	0.0029	CcSEcCtD
Vecuronium—Angioedema—Losartan—type 2 diabetes mellitus	0.000823	0.00289	CcSEcCtD
Vecuronium—Shock—Metformin—type 2 diabetes mellitus	0.000815	0.00286	CcSEcCtD
Vecuronium—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000812	0.00285	CcSEcCtD
Vecuronium—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000812	0.00285	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000809	0.00285	CcSEcCtD
Vecuronium—Skin disorder—Metformin—type 2 diabetes mellitus	0.000804	0.00283	CcSEcCtD
Vecuronium—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000802	0.00282	CcSEcCtD
Vecuronium—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.0008	0.00281	CcSEcCtD
Vecuronium—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000786	0.00276	CcSEcCtD
Vecuronium—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000781	0.00275	CcSEcCtD
Vecuronium—Hypotension—Metformin—type 2 diabetes mellitus	0.000774	0.00272	CcSEcCtD
Vecuronium—Erythema—Ramipril—type 2 diabetes mellitus	0.000772	0.00272	CcSEcCtD
Vecuronium—Shock—Irbesartan—type 2 diabetes mellitus	0.000769	0.0027	CcSEcCtD
Vecuronium—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000766	0.00269	CcSEcCtD
Vecuronium—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000763	0.00268	CcSEcCtD
Vecuronium—Rash—Bromocriptine—type 2 diabetes mellitus	0.00076	0.00267	CcSEcCtD
Vecuronium—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000759	0.00267	CcSEcCtD
Vecuronium—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000759	0.00267	CcSEcCtD
Vecuronium—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000735	0.00259	CcSEcCtD
Vecuronium—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00073	0.00257	CcSEcCtD
Vecuronium—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000729	0.00256	CcSEcCtD
Vecuronium—Shock—Losartan—type 2 diabetes mellitus	0.000723	0.00254	CcSEcCtD
Vecuronium—Urticaria—Valsartan—type 2 diabetes mellitus	0.000722	0.00254	CcSEcCtD
Vecuronium—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000721	0.00254	CcSEcCtD
Vecuronium—Tachycardia—Losartan—type 2 diabetes mellitus	0.000718	0.00252	CcSEcCtD
Vecuronium—Urticaria—Orlistat—type 2 diabetes mellitus	0.000714	0.00251	CcSEcCtD
Vecuronium—Angioedema—Ramipril—type 2 diabetes mellitus	0.000706	0.00248	CcSEcCtD
Vecuronium—Rash—Glyburide—type 2 diabetes mellitus	0.000695	0.00244	CcSEcCtD
Vecuronium—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000694	0.00244	CcSEcCtD
Vecuronium—Hypotension—Losartan—type 2 diabetes mellitus	0.000687	0.00242	CcSEcCtD
Vecuronium—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00067	0.00236	CcSEcCtD
Vecuronium—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000662	0.00233	CcSEcCtD
Vecuronium—Urticaria—Metformin—type 2 diabetes mellitus	0.000658	0.00231	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000653	0.0023	CcSEcCtD
Vecuronium—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00063	0.00222	CcSEcCtD
Vecuronium—Rash—Gliclazide—type 2 diabetes mellitus	0.000624	0.00219	CcSEcCtD
Vecuronium—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000623	0.00219	CcSEcCtD
Vecuronium—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000621	0.00218	CcSEcCtD
Vecuronium—Shock—Ramipril—type 2 diabetes mellitus	0.00062	0.00218	CcSEcCtD
Vecuronium—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000618	0.00217	CcSEcCtD
Vecuronium—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000615	0.00216	CcSEcCtD
Vecuronium—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000612	0.00215	CcSEcCtD
Vecuronium—Hypotension—Ramipril—type 2 diabetes mellitus	0.000589	0.00207	CcSEcCtD
Vecuronium—Urticaria—Losartan—type 2 diabetes mellitus	0.000584	0.00205	CcSEcCtD
Vecuronium—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000576	0.00202	CcSEcCtD
Vecuronium—Rash—Valsartan—type 2 diabetes mellitus	0.000573	0.00202	CcSEcCtD
Vecuronium—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000573	0.00201	CcSEcCtD
Vecuronium—Rash—Orlistat—type 2 diabetes mellitus	0.000566	0.00199	CcSEcCtD
Vecuronium—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000566	0.00199	CcSEcCtD
Vecuronium—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000542	0.0019	CcSEcCtD
Vecuronium—Rash—Metformin—type 2 diabetes mellitus	0.000522	0.00184	CcSEcCtD
Vecuronium—Dermatitis—Metformin—type 2 diabetes mellitus	0.000522	0.00183	CcSEcCtD
Vecuronium—Urticaria—Ramipril—type 2 diabetes mellitus	0.000501	0.00176	CcSEcCtD
Vecuronium—Rash—Irbesartan—type 2 diabetes mellitus	0.000493	0.00173	CcSEcCtD
Vecuronium—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000492	0.00173	CcSEcCtD
Vecuronium—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000464	0.00163	CcSEcCtD
Vecuronium—Rash—Losartan—type 2 diabetes mellitus	0.000464	0.00163	CcSEcCtD
Vecuronium—Dermatitis—Losartan—type 2 diabetes mellitus	0.000463	0.00163	CcSEcCtD
Vecuronium—Rash—Ramipril—type 2 diabetes mellitus	0.000398	0.0014	CcSEcCtD
Vecuronium—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000397	0.0014	CcSEcCtD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	8.45e-05	0.00165	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	8.35e-05	0.00163	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.02e-05	0.00156	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—type 2 diabetes mellitus	7.98e-05	0.00156	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	7.51e-05	0.00146	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	7.49e-05	0.00146	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—BHMT—type 2 diabetes mellitus	7.48e-05	0.00146	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP8—type 2 diabetes mellitus	7.41e-05	0.00144	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	7.25e-05	0.00141	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—GNB3—type 2 diabetes mellitus	7.18e-05	0.0014	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	7.18e-05	0.0014	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	6.95e-05	0.00135	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	6.9e-05	0.00134	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	6.83e-05	0.00133	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	6.74e-05	0.00131	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	6.59e-05	0.00128	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	6.59e-05	0.00128	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTGDS—type 2 diabetes mellitus	6.54e-05	0.00127	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AANAT—type 2 diabetes mellitus	6.54e-05	0.00127	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—ADCY5—type 2 diabetes mellitus	6.4e-05	0.00125	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPD2—type 2 diabetes mellitus	6.2e-05	0.00121	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CDO1—type 2 diabetes mellitus	6.2e-05	0.00121	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	6.05e-05	0.00118	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.03e-05	0.00118	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	6.03e-05	0.00118	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AK1—type 2 diabetes mellitus	5.91e-05	0.00115	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.76e-05	0.00112	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.76e-05	0.00112	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	5.62e-05	0.0011	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	5.6e-05	0.00109	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	5.59e-05	0.00109	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	5.57e-05	0.00109	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	5.56e-05	0.00108	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	5.51e-05	0.00107	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—CALM1—type 2 diabetes mellitus	5.5e-05	0.00107	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	5.49e-05	0.00107	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC5A4—type 2 diabetes mellitus	5.46e-05	0.00106	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MAT1A—type 2 diabetes mellitus	5.46e-05	0.00106	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	5.38e-05	0.00105	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	5.38e-05	0.00105	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ND1—type 2 diabetes mellitus	5.27e-05	0.00103	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—G6PC—type 2 diabetes mellitus	5.27e-05	0.00103	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ENPP1—type 2 diabetes mellitus	5.27e-05	0.00103	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HBA2—type 2 diabetes mellitus	5.27e-05	0.00103	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.27e-05	0.00103	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	5.17e-05	0.00101	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	5.17e-05	0.00101	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—PRKCB—type 2 diabetes mellitus	5.17e-05	0.00101	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GCGR—type 2 diabetes mellitus	5.1e-05	0.000994	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.08e-05	0.00099	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.9e-05	0.000954	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYTB—type 2 diabetes mellitus	4.82e-05	0.000939	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—OXCT1—type 2 diabetes mellitus	4.82e-05	0.000939	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	4.76e-05	0.000927	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	4.74e-05	0.000923	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	4.7e-05	0.000915	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.7e-05	0.000915	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.67e-05	0.00091	CbGpPWpGaD
Vecuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	4.54e-05	0.000885	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD17B3—type 2 diabetes mellitus	4.48e-05	0.000873	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ACACA—type 2 diabetes mellitus	4.48e-05	0.000873	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—STAR—type 2 diabetes mellitus	4.48e-05	0.000873	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	4.48e-05	0.000873	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	4.4e-05	0.000857	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	4.38e-05	0.000854	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	4.37e-05	0.000851	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CBS—type 2 diabetes mellitus	4.3e-05	0.000837	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCC8—type 2 diabetes mellitus	4.3e-05	0.000837	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.25e-05	0.000828	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—COX2—type 2 diabetes mellitus	4.13e-05	0.000806	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC5A2—type 2 diabetes mellitus	4.13e-05	0.000806	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	4.08e-05	0.000794	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.07e-05	0.000794	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA6—type 2 diabetes mellitus	4.06e-05	0.000791	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.99e-05	0.000778	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UCP3—type 2 diabetes mellitus	3.99e-05	0.000778	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UCP2—type 2 diabetes mellitus	3.99e-05	0.000778	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.86e-05	0.000752	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.84e-05	0.000749	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	3.83e-05	0.000747	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	3.83e-05	0.000747	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.81e-05	0.000742	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PCK1—type 2 diabetes mellitus	3.75e-05	0.000732	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.68e-05	0.000717	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	3.66e-05	0.000712	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	3.63e-05	0.000708	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	3.63e-05	0.000708	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	3.59e-05	0.0007	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	3.54e-05	0.000689	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HK1—type 2 diabetes mellitus	3.52e-05	0.000685	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	3.5e-05	0.000683	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	3.46e-05	0.000675	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.44e-05	0.00067	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD3B2—type 2 diabetes mellitus	3.4e-05	0.000662	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GCKR—type 2 diabetes mellitus	3.4e-05	0.000662	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—KCNJ11—type 2 diabetes mellitus	3.4e-05	0.000662	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LPA—type 2 diabetes mellitus	3.4e-05	0.000662	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.38e-05	0.000658	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.38e-05	0.000658	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.29e-05	0.000642	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.28e-05	0.000638	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.26e-05	0.000635	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALDOB—type 2 diabetes mellitus	3.26e-05	0.000634	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	3.2e-05	0.000623	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	3.2e-05	0.000623	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	3.14e-05	0.000611	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.1e-05	0.000605	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	3.09e-05	0.000602	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	3.09e-05	0.000602	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.09e-05	0.000602	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	3.09e-05	0.000602	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	3.09e-05	0.000602	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GLP1R—type 2 diabetes mellitus	3.03e-05	0.00059	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	2.99e-05	0.000583	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.98e-05	0.000581	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.91e-05	0.000567	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	2.87e-05	0.000559	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.83e-05	0.000551	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	2.82e-05	0.00055	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	2.82e-05	0.00055	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CPT1A—type 2 diabetes mellitus	2.77e-05	0.000539	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTR—type 2 diabetes mellitus	2.77e-05	0.000539	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	2.77e-05	0.000539	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	2.75e-05	0.000536	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	2.74e-05	0.000534	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NAMPT—type 2 diabetes mellitus	2.71e-05	0.000529	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HBA1—type 2 diabetes mellitus	2.7e-05	0.000526	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LIPC—type 2 diabetes mellitus	2.7e-05	0.000526	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GCK—type 2 diabetes mellitus	2.7e-05	0.000526	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.68e-05	0.000522	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.63e-05	0.000513	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	2.63e-05	0.000512	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	2.63e-05	0.000512	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	2.63e-05	0.000512	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	2.62e-05	0.000511	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CETP—type 2 diabetes mellitus	2.6e-05	0.000507	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	2.59e-05	0.000504	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	2.52e-05	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	2.52e-05	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	2.42e-05	0.000472	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	2.42e-05	0.000472	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	2.42e-05	0.000471	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	2.42e-05	0.000471	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	2.42e-05	0.000471	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.41e-05	0.00047	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	2.38e-05	0.000464	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	2.37e-05	0.000463	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	2.35e-05	0.000459	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.35e-05	0.000457	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	2.34e-05	0.000456	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	2.34e-05	0.000456	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	2.34e-05	0.000456	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.31e-05	0.00045	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.3e-05	0.000449	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.26e-05	0.000441	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.25e-05	0.000439	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.23e-05	0.000435	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.21e-05	0.000431	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	2.2e-05	0.000429	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.19e-05	0.000426	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.19e-05	0.000426	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.16e-05	0.00042	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.15e-05	0.00042	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.13e-05	0.000416	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.11e-05	0.000412	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	2.1e-05	0.000409	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.1e-05	0.000409	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	2.06e-05	0.000402	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.02e-05	0.000393	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.01e-05	0.000392	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.99e-05	0.000388	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.99e-05	0.000388	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.99e-05	0.000388	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.99e-05	0.000388	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.91e-05	0.000372	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.82e-05	0.000355	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.81e-05	0.000352	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	1.81e-05	0.000352	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.8e-05	0.000351	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	1.78e-05	0.000346	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.77e-05	0.000346	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	1.72e-05	0.000336	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.71e-05	0.000333	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.68e-05	0.000327	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.66e-05	0.000323	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	1.65e-05	0.000321	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.62e-05	0.000316	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.62e-05	0.000316	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.61e-05	0.000314	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	1.61e-05	0.000313	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.59e-05	0.00031	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.58e-05	0.000308	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.58e-05	0.000308	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.58e-05	0.000308	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.57e-05	0.000306	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	1.56e-05	0.000305	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.54e-05	0.000301	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.54e-05	0.000301	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.53e-05	0.000297	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.5e-05	0.000292	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.48e-05	0.000289	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	1.45e-05	0.000283	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.42e-05	0.000276	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.42e-05	0.000276	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.42e-05	0.000276	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	1.41e-05	0.000274	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.39e-05	0.000271	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	1.38e-05	0.00027	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	1.38e-05	0.000269	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.38e-05	0.000269	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	1.36e-05	0.000266	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.35e-05	0.000263	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.35e-05	0.000263	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.3e-05	0.000253	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.28e-05	0.00025	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.28e-05	0.00025	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.25e-05	0.000244	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.23e-05	0.00024	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.23e-05	0.00024	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	1.2e-05	0.000234	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	1.18e-05	0.00023	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	1.08e-05	0.000211	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.06e-05	0.000206	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.06e-05	0.000206	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.05e-05	0.000206	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.04e-05	0.000203	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.03e-05	0.000201	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.03e-05	0.000201	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.01e-05	0.000197	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	9.83e-06	0.000192	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.65e-06	0.000188	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	9.45e-06	0.000184	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	9.44e-06	0.000184	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	9.41e-06	0.000183	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	9.17e-06	0.000179	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.05e-06	0.000176	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.69e-06	0.000169	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.52e-06	0.000166	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	8.25e-06	0.000161	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	8.12e-06	0.000158	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	8.09e-06	0.000158	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	7.99e-06	0.000156	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	7.04e-06	0.000137	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—INS—type 2 diabetes mellitus	6.91e-06	0.000135	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	6.33e-06	0.000123	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	6.06e-06	0.000118	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.06e-06	0.000118	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.54e-06	0.000108	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	4.75e-06	9.26e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.78e-06	5.43e-05	CbGpPWpGaD
